Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ICOSLG Antikörper (Internal Region)

Verified ICOSLG Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
Produktnummer ABIN2851823
  • Target Alle ICOSLG Antikörper anzeigen
    ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
    Bindungsspezifität
    • 8
    • 7
    • 7
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Internal Region
    Reaktivität
    • 68
    • 13
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 43
    • 27
    • 6
    Ziege
    Klonalität
    • 39
    • 36
    • 1
    Polyklonal
    Konjugat
    • 45
    • 8
    • 8
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser ICOSLG Antikörper ist unkonjugiert
    Applikation
    • 43
    • 35
    • 26
    • 16
    • 6
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Verwendungszweck
    ICOS ligand / B7-H2
    Sequenz
    SQTGNDIGER DKIT
    Spezifität
    This antibody is expected to recognize all reported isoforms (NP_056074.1, NP_001269979.1, NP_001269980.1, NP_001269981.1).
    Kreuzreaktivität
    Human
    Aufreinigung
    Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
    Güteklasse
    Verified
    Isotyp
    IgG
    Top Product
    Discover our top product ICOSLG Primärantikörper
  • Applikationshinweise

    Western Blot: Approx 33 kDa band observed in Human Lymph Node lysates (calculated MW of 33.3 kDa according to NP_056074.1). Recommended concentration: 1-3 μg/mL.

    Peptide ELISA: antibody detection limit dilution 1:8000.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.5 mg/mL
    Buffer
    Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Minimize freezing and thawing.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
  • Target
    ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
    Andere Bezeichnung
    ICOSLG (ICOSLG Produkte)
    Synonyme
    ICOSLG antikoerper, AU044799 antikoerper, B7-H2 antikoerper, B7RP-1 antikoerper, B7h antikoerper, BG071784 antikoerper, GI50 antikoerper, GL50 antikoerper, GL50-B antikoerper, ICOS-L antikoerper, Icoslg antikoerper, LICOS antikoerper, Ly115l antikoerper, mKIAA0653 antikoerper, B7H2 antikoerper, B7RP1 antikoerper, CD275 antikoerper, ICOSL antikoerper, Icosl antikoerper, RGD1562791 antikoerper, inducible T-cell costimulator ligand antikoerper, icos ligand antikoerper, inducible T-cell co-stimulator ligand antikoerper, ICOSLG antikoerper, Icosl antikoerper, Icoslg antikoerper
    Hintergrund
    ICOSLG, inducible T-cell co-stimulator ligand, B7-H2, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, LICOS, B7 homolog 2, B7 homologue 2, B7-like protein Gl50, B7-related protein 1, ICOS ligand, transmembrane protein B7-H2 ICOS ligand
    Gen-ID
    23308
    NCBI Accession
    NP_056074, NP_001269979, NP_001269980, NP_001269981
    Pathways
    Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Sie sind hier:
Kundenservice